HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhi Cheng Selected Research

Therapeutics

12/2023An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously.
1/2022One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.
1/2022CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status.
3/2021Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
1/2019Using Pan RNA-Seq Analysis to Reveal the Ubiquitous Existence of 5' and 3' End Small RNAs.
1/2018Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
12/2017Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.
1/2016Human and Murine Tissue-Engineered Colon Exhibit Diverse Neuronal Subtypes and Can Be Populated by Enteric Nervous System Progenitor Cells When Donor Colon Is Aganglionic.
6/2008In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhi Cheng Research Topics

Disease

9Neoplasms (Cancer)
03/2024 - 06/2008
9Head and Neck Neoplasms (Head and Neck Cancer)
08/2021 - 12/2017
5Enterocolitis
01/2019 - 02/2011
4Multiple Myeloma
12/2023 - 04/2020
4COVID-19
11/2023 - 01/2022
4Xerostomia
03/2020 - 01/2019
3Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2017
3Weight Loss (Weight Reduction)
07/2020 - 07/2018
2Pain (Aches)
03/2024 - 06/2014
2Inflammation (Inflammations)
03/2023 - 01/2022
2Neurodegenerative Diseases (Neurodegenerative Disease)
08/2019 - 12/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2018 - 10/2018
2Deglutition Disorders (Dysphagia)
01/2018 - 12/2017
2Lymphopenia (Lymphocytopenia)
03/2015 - 02/2011
1Colorectal Neoplasms (Colorectal Cancer)
04/2024
1Neuralgia (Stump Neuralgia)
03/2024
1Dyskinesias (Dyskinesia)
02/2024
1Disease Progression
12/2023
1Chronic Disease (Chronic Diseases)
12/2023
1Hypotension (Low Blood Pressure)
01/2023
1Vertigo (Positional Vertigo)
01/2023
1Cough
01/2022
1Cough-Variant Asthma
01/2022
1Oropharyngeal Neoplasms
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Cytokine Release Syndrome
01/2022
1Citrullinemia
01/2022
1Dermatitis
08/2021
1Adenocarcinoma
03/2021
1Cardiomegaly (Heart Hypertrophy)
11/2020
1Lung Neoplasms (Lung Cancer)
07/2020
1Mental Disorders (Mental Disorder)
08/2019
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019
1Fetomaternal Transfusion
04/2018
1Choriocarcinoma
04/2018
1Cognitive Dysfunction
01/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2017
1Substance-Related Disorders (Drug Abuse)
08/2016
1Hypertrophy
02/2016
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
01/2016
1Hirschsprung Disease (Hirschsprung's Disease)
01/2016
1Ventricular Heart Septal Defects (Ventricular Septal Defect)
12/2015
1Squamous Cell Carcinoma of Head and Neck
06/2014
1Squamous Cell Neoplasms (Squamous Cell Cancer)
06/2014

Drug/Important Bio-Agent (IBA)

5U1 small nuclear RNAIBA
01/2021 - 08/2017
3bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2023 - 01/2022
3Proteins (Proteins, Gene)FDA Link
04/2020 - 12/2015
3Endothelin Receptors (Endothelin Receptor)IBA
01/2018 - 02/2011
2Chimeric Antigen ReceptorsIBA
12/2023 - 01/2022
2RNA (Ribonucleic Acid)IBA
11/2023 - 08/2019
2Heparin (Liquaemin)FDA LinkGeneric
03/2022 - 02/2022
2Polysaccharides (Glycans)IBA
03/2022 - 02/2022
2Small Nuclear RNA (snRNA)IBA
01/2021 - 08/2017
2Transcription Factors (Transcription Factor)IBA
02/2016 - 12/2015
1Epidermal Growth Factor (EGF)IBA
03/2024
1ZearalenoneIBA
02/2024
1Caspase 8 (Caspase-8)IBA
02/2024
1Dietary FiberFDA Link
12/2023
1vadimezanIBA
03/2023
1InterferonsIBA
03/2023
1Oxidoreductases (Dehydrogenase)IBA
01/2023
1Propofol (Diprivan)FDA LinkGeneric
01/2023
1remimazolamIBA
01/2023
1Leukotriene C4IBA
01/2022
1Leukotriene B4IBA
01/2022
1B-Cell Maturation AntigenIBA
01/2022
1Immunoglobulin D (IgD)IBA
01/2022
1Urea (Carbamide)FDA LinkGeneric
01/2022
1CitrullineIBA
01/2022
1Lenalidomide (CC 5013)FDA Link
01/2022
1Presenilin-1IBA
01/2021
1Long Noncoding RNAIBA
11/2020
1Messenger RNA (mRNA)IBA
04/2020
1ribonucleotide reductase M2IBA
04/2020
1Anti-Idiotypic AntibodiesIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1AntibodiesIBA
01/2019
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2019
1MannansIBA
01/2019
1Ribonuclease III (RNase III)IBA
01/2019
1PorinsIBA
01/2019
1HydrogelsIBA
11/2018
1AntigensIBA
10/2018
1CarbohydratesIBA
10/2018
1Neuroprotective AgentsIBA
01/2018
1Amyloid (Amyloid Fibrils)IBA
08/2017
1CytokinesIBA
02/2017
1Parathyroid Hormone-Related ProteinIBA
02/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Volatile Fatty AcidsIBA
01/2016
1Twist-Related Protein 1IBA
12/2015
1Endothelins (Endothelin)IBA
03/2015

Therapy/Procedure

14Radiotherapy
03/2024 - 08/2016
9Therapeutics
12/2023 - 06/2008
4Drug Therapy (Chemotherapy)
07/2020 - 04/2008
3Aftercare (After-Treatment)
03/2024 - 12/2017
1Fluid Therapy (Oral Rehydration Therapy)
04/2024
1Length of Stay
04/2024
1Free Tissue Flaps
01/2022
1Transplantation
01/2022